The Research and Advisory Team at RosVivo Therapeutics conducts cutting-edge scientific research to advance miRNA and siRNA therapies, focusing on type 2 diabetes, obesity, and COVID-19. The team leverages unique insights to drive the development of novel drug candidates and diagnostic tests while providing strategic direction and expert consultation to guide the company's therapeutic pipeline.